OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
OCAT was delisted on the 9th of February, 2016.
1 hedge funds and large institutions have $0 invested in OCATA THERAPEUTICS, INC. COMMON STOCK in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 75 closing their positions.
99% less funds holding
Funds holding: 77 → 1 (-76)
100% less capital invested
Capital invested by funds: $135M → $0 (-$135M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 75
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$20.3M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
-$14.2M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$13.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.6M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$9.89M |
OCAT Hedge Fund Activity: Q1 2016 in Review
1 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) for Q1 2016, worth a combined $0 — down 100% from $135M a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of OCAT and 0 opened new positions — a net loss of 75 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Alpine Associates Management, exiting entirely with an estimated $20.3M sold.
- 1 institutional investor held OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) as of Q1 2016, down from 77 in Q4 2015.
- Funds reported $0 of OCATA THERAPEUTICS, INC. COMMON STOCK stock for Q1 2016, down 100% quarter-over-quarter.
- 0 funds opened new OCATA THERAPEUTICS, INC. COMMON STOCK positions in Q1 2016 and 75 closed out, a net change of -75 holders.
- The largest OCATA THERAPEUTICS, INC. COMMON STOCK seller in Q1 2016 was Alpine Associates Management, an estimated $20.3M sold.
Based on aggregated 13F filings for Q1 2016.